Sandoz Group (OTCMKTS:SDZNY) Trading 1% Higher – Here’s What Happened

Sandoz Group AG (OTCMKTS:SDZNY) shares traded up 1% on Thursday . The company traded as high as $42.49 and last traded at $41.71. 19,907 shares were traded during trading, a decline of 79% from the average session volume of 92,822 shares. The stock had previously closed at $41.31.

Wall Street Analyst Weigh In

SDZNY has been the topic of a number of research analyst reports. Royal Bank of Canada downgraded Sandoz Group from a “moderate buy” rating to a “hold” rating in a research note on Monday, September 16th. BNP Paribas downgraded Sandoz Group from a “strong-buy” rating to a “hold” rating in a research report on Monday, December 2nd.

Sandoz Group Stock Performance

The company has a 50 day moving average of $44.02 and a 200-day moving average of $41.68.

Sandoz Group Company Profile

Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.